{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T10:19:40Z","timestamp":1725790780215},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.cca.2006.08.010","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T12:06:29Z","timestamp":1155643589000},"page":"240-243","source":"Crossref","is-referenced-by-count":16,"title":["Concordance between the deduced acetylation status generated by high-speed Real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay"],"prefix":"10.1016","volume":"376","author":[{"given":"Hans-Peter","family":"Rihs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scherenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2006.08.010_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/clpt.1983.80","article-title":"Variability in caffeine metabolism","volume":"33","author":"Grant","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2006.08.010_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-4347(00)00616-2","article-title":"Extraction less method for the simultaneous high performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment","volume":"755","author":"Ny\u00e9ki","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.cca.2006.08.010_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0027-5107(02)00153-7","article-title":"Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis","volume":"506\u2013507","author":"Hein","year":"2002","journal-title":"Mutat Res"},{"key":"10.1016\/j.cca.2006.08.010_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0027-5107(97)00026-2","article-title":"Human acetyltransferase polymorphisms","volume":"376","author":"Grant","year":"1997","journal-title":"Mutat Res"},{"key":"10.1016\/j.cca.2006.08.010_bib5","doi-asserted-by":"crossref","first-page":"D528","DOI":"10.1093\/nar\/gkh005","article-title":"SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes","volume":"32","author":"Packer","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cca.2006.08.010_bib6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","article-title":"Genotype\/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele in African-Americans","volume":"14","author":"Bell","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cca.2006.08.010_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1055-9965.1543.13.9","article-title":"Impact of misclassification in genotype-exposure interaction studies: example of N-Acetyltransferase 2 (NAT2), smoking and bladder cancer","volume":"13","author":"Deitz","year":"2004","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.cca.2006.08.010_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.toxlet.2005.02.012","article-title":"Occupational exposure to polycyclic aromatic hydrocarbons in German industries: Association between exogenous exposure and urinary metabolites and its modulation by enzyme polymorphisms","volume":"157","author":"Rihs","year":"2005","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cca.2006.08.010_bib9","first-page":"581","article-title":"Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotyping activity","volume":"57","author":"Cascorbi","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cca.2006.08.010_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00204-004-0622-8","article-title":"Re-investigation of the concordance of human NAT2 phenotypes and genotypes","volume":"79","author":"Bolt","year":"2005","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.cca.2006.08.010_bib11","first-page":"683","article-title":"Distribution of N-acetytransferase genotype and phenotype in an American population","volume":"8","author":"Gross","year":"1999","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.cca.2006.08.010_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00008571-200201000-00006","article-title":"Analysis of six SNPs in Ngawbe and Embera Ameridians of Panama and determination of the Embera acetylation phenotype using caffeine","volume":"12","author":"Jorge-Nebert","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cca.2006.08.010_bib13","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.cca.2006.08.010_bib14","first-page":"3531","article-title":"Metabolic activation of N-hydroxlamines and N-hydroxlamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions","volume":"55","author":"Hein","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2006.08.010_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00008571-200003000-00009","article-title":"Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype","volume":"10","author":"O'Neil","year":"1999","journal-title":"Pharmacogenetics"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106004980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106004980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T14:32:45Z","timestamp":1683556365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898106004980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0009898106004980"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2006.08.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}